Voya Investment Management LLC Has $23.64 Million Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Voya Investment Management LLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 63.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 78,775 shares of the company's stock after selling 136,802 shares during the quarter. Voya Investment Management LLC's holdings in HCA Healthcare were worth $23,644,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of HCA. Whipplewood Advisors LLC acquired a new position in HCA Healthcare during the fourth quarter worth $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare during the 4th quarter worth $36,000. Activest Wealth Management increased its holdings in HCA Healthcare by 1,250.0% during the 4th quarter. Activest Wealth Management now owns 135 shares of the company's stock valued at $40,000 after acquiring an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. grew its position in shares of HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Finally, Eastern Bank acquired a new position in shares of HCA Healthcare in the fourth quarter worth $62,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at approximately $4,971,757.08. The trade was a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on HCA. Cantor Fitzgerald reissued an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. StockNews.com upgraded HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday. Barclays lowered their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a research note on Monday, January 27th. Robert W. Baird reissued a "neutral" rating and issued a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Finally, Truist Financial reduced their price objective on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, twelve have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average price target of $381.13.

HCA Healthcare Stock Up 1.4 %

HCA Healthcare stock traded up $4.90 during trading hours on Friday, hitting $347.94. The company had a trading volume of 400,655 shares, compared to its average volume of 1,395,034. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The firm has a market capitalization of $85.66 billion, a P/E ratio of 15.83, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The firm's fifty day moving average is $331.50 and its 200-day moving average is $331.12.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating the consensus estimate of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter in the previous year, the business posted $5.36 EPS. The firm's quarterly revenue was up 5.7% compared to the same quarter last year. On average, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.83%. HCA Healthcare's dividend payout ratio is presently 12.81%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.